pubmed-article:6605019 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C0021294 | lld:lifeskim |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C0392209 | lld:lifeskim |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C0042866 | lld:lifeskim |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C0014695 | lld:lifeskim |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C2348609 | lld:lifeskim |
pubmed-article:6605019 | lifeskim:mentions | umls-concept:C0439505 | lld:lifeskim |
pubmed-article:6605019 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:6605019 | pubmed:dateCreated | 1983-11-23 | lld:pubmed |
pubmed-article:6605019 | pubmed:abstractText | The vitamin D nutritional status of premature infants was assessed by determining plasma 25-hydroxyvitamin D concentrations before and during supplementation with 500 IU vitamin D2 per day. Fifty-one samples were collected from 25 healthy infants fed breast milk and a vitamin D3 fortified formula. Gestational age was 32.2 +/- 2.4 weeks (mean +/- 1 SD). 25-hydroxyvitamin D levels before supplementation correlated well with maternal values (r = 0.81). The infants' mean plasma concentration increased from 30.6 +/- 13.7 nmol/l (mean +/- 1 SD) after birth to 46.3 +/- 10.5 nmol/l after 9 +/- 1 days (p less than 0.0025), and to 65.3 +/- 16.6 nmol/l after 37 +/- 10 days of vitamin D2 treatment (p less than 0.0005). 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 were determined separately, and it appeared that the rise was accounted for by the D2 fraction while 25-hydroxyvitamin D3 concentrations were unchanged. The results demonstrate that vitamin D2 is well absorbed and hydroxylated in the 25 position by premature infants free of associated disease, and that a supplementation of 500 IU per day in addition to breast milk and a regular vitamin D fortified formula is adequate to rapidly establish 25-hydroxyvitamin D levels within the normal adult range. | lld:pubmed |
pubmed-article:6605019 | pubmed:language | eng | lld:pubmed |
pubmed-article:6605019 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6605019 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6605019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6605019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6605019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6605019 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6605019 | pubmed:month | Jul | lld:pubmed |
pubmed-article:6605019 | pubmed:issn | 0001-656X | lld:pubmed |
pubmed-article:6605019 | pubmed:author | pubmed-author:FinneP HPH | lld:pubmed |
pubmed-article:6605019 | pubmed:author | pubmed-author:AksnesLL | lld:pubmed |
pubmed-article:6605019 | pubmed:author | pubmed-author:AarskogDD | lld:pubmed |
pubmed-article:6605019 | pubmed:author | pubmed-author:MarkestadTT | lld:pubmed |
pubmed-article:6605019 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6605019 | pubmed:volume | 72 | lld:pubmed |
pubmed-article:6605019 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6605019 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6605019 | pubmed:pagination | 517-20 | lld:pubmed |
pubmed-article:6605019 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:meshHeading | pubmed-meshheading:6605019-... | lld:pubmed |
pubmed-article:6605019 | pubmed:year | 1983 | lld:pubmed |
pubmed-article:6605019 | pubmed:articleTitle | Vitamin D nutritional status of premature infants supplemented with 500 IU vitamin D2 per day. | lld:pubmed |
pubmed-article:6605019 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6605019 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:6605019 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |